Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,091 | 199 | 95.6% |
| Education | $189.95 | 2 | 4.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SHIELD THERAPEUTICS INC | $514.15 | 6 | $0 (2024) |
| Astellas Pharma US Inc | $369.89 | 15 | $0 (2024) |
| Daiichi Sankyo Inc. | $348.66 | 13 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $311.78 | 21 | $0 (2024) |
| Janssen Biotech, Inc. | $303.50 | 22 | $0 (2024) |
| Celgene Corporation | $280.76 | 15 | $0 (2024) |
| Merck Sharp & Dohme LLC | $264.21 | 13 | $0 (2024) |
| Incyte Corporation | $149.94 | 7 | $0 (2024) |
| GlaxoSmithKline, LLC. | $143.67 | 6 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $139.24 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,113 | 144 | SHIELD THERAPEUTICS INC ($514.15) |
| 2023 | $902.79 | 48 | Celgene Corporation ($100.01) |
| 2022 | $137.52 | 4 | Takeda Pharmaceuticals U.S.A., Inc. ($73.68) |
| 2021 | $128.06 | 5 | Celgene Corporation ($57.37) |
All Payment Transactions
201 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $8.93 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, TALVEY | Food and Beverage | In-kind items and services | $0.50 | General |
| Category: Oncology | ||||||
| 12/06/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: ONCOLOGY | ||||||
| 11/22/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $15.89 | General |
| Category: Oncology | ||||||
| 11/20/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: ONCOLOGY | ||||||
| 11/18/2024 | Incyte Corporation | PEMAZYRE (Drug), JAKAFI, MONJUVI | Food and Beverage | Cash or cash equivalent | $21.58 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 11/15/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Astellas Pharma US Inc | Vyloy (Drug) | Food and Beverage | In-kind items and services | $27.13 | General |
| Category: Oncology | ||||||
| 11/08/2024 | Genmab U.S., Inc. | Tivdak (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Oncology | ||||||
| 11/08/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.93 | General |
| 11/07/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Oncology | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $31.92 | General |
| Category: Oncology | ||||||
| 11/01/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $14.86 | General |
| Category: Hematology | ||||||
| 10/31/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological), TALVEY, DARZALEX | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Oncology | ||||||
| 10/30/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2024 | Coherus Biosciences Inc. | Udenyca (Biological) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: Granulocyte colony stimulating factor | ||||||
| 10/28/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $119.43 | General |
| Category: Hematology | ||||||
| 10/15/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $11.13 | General |
| Category: Oncology | ||||||
| 10/11/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: ONCOLOGY | ||||||
| 10/11/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: ONCOLOGY | ||||||
| 10/09/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $31.63 | General |
| Category: ONCOLOGY | ||||||
| 09/30/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: ONCOLOGY | ||||||
| 09/27/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 09/24/2024 | Astellas Pharma US Inc | Padcev (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 49 | 53 | $7,346 | $2,879 |
| 2022 | 3 | 106 | 110 | $39,376 | $8,766 |
| 2021 | 4 | 140 | 163 | $56,135 | $13,138 |
| 2020 | 3 | 58 | 66 | $22,334 | $5,010 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 34 | 37 | $6,050 | $2,201 | 36.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 15 | 16 | $1,296 | $678.40 | 52.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 61 | 62 | $19,468 | $3,621 | 18.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 27 | 30 | $11,340 | $2,798 | 24.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 18 | 18 | $8,568 | $2,347 | 27.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 71 | 74 | $21,904 | $4,774 | 21.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 39 | 44 | $15,664 | $3,954 | 25.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 18 | 21 | $9,597 | $2,775 | 28.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 12 | 24 | $8,970 | $1,635 | 18.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 20 | 28 | $9,716 | $1,952 | 20.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 14 | 14 | $5,922 | $1,940 | 32.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 24 | 24 | $6,696 | $1,119 | 16.7% |
About Sarah Eplion, APRN, FNP-BC
Sarah Eplion, APRN, FNP-BC is a Family healthcare provider based in Ashland, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/07/2018. The National Provider Identifier (NPI) number assigned to this provider is 1427529130.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sarah Eplion, APRN, FNP-BC has received a total of $4,281 in payments from pharmaceutical and medical device companies, with $3,113 received in 2024. These payments were reported across 201 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($4,091).
As a Medicare-enrolled provider, Eplion has provided services to 353 Medicare beneficiaries, totaling 392 services with total Medicare billing of $29,793. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Family
- Other Specialties Family
- Location Ashland, KY
- Active Since 12/07/2018
- Last Updated 03/16/2023
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1427529130
Products in Payments
- ACCRUFER (Drug) $514.15
- Enhertu (Drug) $348.66
- KEYTRUDA (Biological) $264.21
- KISQALI (Drug) $191.79
- REBLOZYL (Biological) $168.52
- Udenyca (Biological) $135.70
- ZEJULA (Drug) $127.10
- JAKAFI (Drug) $107.19
- Padcev (Drug) $96.21
- VENCLEXTA (Drug) $86.56
- ZEPZELCA (Drug) $83.19
- ERLEADA (Drug) $82.09
- MONOFERRIC (Drug) $77.59
- OPDUALAG (Drug) $75.95
- Nubeqa (Drug) $73.26
- TALVEY (Biological) $69.05
- Orserdu (Drug) $64.09
- RYBREVANT (Drug) $60.72
- BESREMI (Drug) $52.45
- PLUVICTO (Drug) $51.71
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Ashland
Mr. Stephen Perkey, Cnp, CNP
Family — Payments: $28,660
Ashley Malone, Msn, Rn, Fnp-Bc, MSN, RN, FNP-BC
Family — Payments: $9,852
Jessica Hicks, Aprn, APRN
Family — Payments: $9,119
Eva Joseph, Aprn, APRN
Family — Payments: $7,607
Brittany Linn
Family — Payments: $7,278
Ms. Brenda Sawyer, Lnp, LNP
Family — Payments: $6,342